Tiny lab-grown brain models and the particles they release may reveal hidden differences among Alzheimer’s patients. Personalized treatment remains one of the biggest challenges in Alzheimer’s disease. Two patients can receive the same medication for symptoms such as depression, anxiety, or agitation and experience very different outcomes, leaving doctors with few ways to predict who [...]
A new study suggests that sleep loss during pregnancy and the postpartum period may be an early driver of anxiety symptoms. Lack of sleep is often treated as an unavoidable part of pregnancy and new parenthood. But what if those restless nights are doing more than leaving parents exhausted? New research suggests sleep loss may [...]
A study at one of Earth’s most isolated research stations offers new clues about how teams adapt during long periods of confinement. When people are isolated in extreme environments, it seems intuitive that spending more time together would strengthen social bonds. But new research suggests that under the right conditions, constant contact may actually create [...]
For five years, an elderly woman with advanced Alzheimer’s diseasehad spoken mostly in single words, needed help walking, and showed little spontaneous interaction with the people around her. Then, roughly 19 hours after receiving a high dose of psilocybin-containing mushrooms, she emerged from a prolonged, deep sleep-like state and began talking about her life.
The striking episode, described in a new case report published in Frontiers in Neuroscience, does not show that psilocybin reverses Alzheimer’s disease. The researchers are careful to stress that this was a single patient, observed in a real-world private clinical setting without brain imaging, formal sleep monitoring, or standardized cognitive testing.
Still, the study’s authors say the case raises the interesting possibility that in late-stage dementia, some functional abilities may indeed remain dormant rather than be completely lost.
“Advanced Alzheimer’s disease is generally regarded as a stage of irreversible functional decline,” researchers write. “This case documents transient multidomain functional improvement in advanced Alzheimer’s disease following psilocybin administration.”
The case involved a Japanese-American woman in her 80s with a 10-year history of Alzheimer’s disease. The patient was described as being in an advanced stage of dementia, with the previous five years being noted for severe decline.
Her speech had become mostly monosyllabic, and she had chronic urinary incontinence, executive dysfunction, dysphagia, dependent mobility, flat affect, prolonged somnolence, and a severe reduction in spontaneous communication.
Her diagnosis had been made clinically about a decade earlier, based on a steadily progressive neurodegenerative course, memory impairment, language reduction, executive dysfunction, and functional decline.
The intervention was a single oral dose of 5 grams of psilocybin-containing mushrooms from the “Enigma” strain. Researchers note that no established psilocybin dosing framework exists for advanced dementia, and the dose was high by almost any comparison.
Recreational users commonly describe 1 to 3 grams of dried Psilocybe cubensis mushrooms as a typical range, while doses around 3.5 grams or more are generally considered strong. A 5-gram dose is often treated as an especially intense experience. However, direct comparisons are imprecise because psilocybin content can vary widely between mushroom species, strains, batches, and even different parts of the same mushroom.
The study also notes that the dose was “relatively high compared with dosing approaches commonly used in modern clinical trials,” which typically use carefully measured amounts of purified psilocybin rather than whole mushrooms.
One month later, after some improvements persisted, the patient underwent a second supervised session using 3 grams.
The first session produced a dramatic acute response. The patient experienced autonomic activation, profuse sweating, suspected hyperthermia, and what the researchers describe as a prolonged deep sleep-like state. Exact temperature measurements were not available.
The study’s timeline shows that the first 12 hours were dominated by autonomic and sleep-like effects. At about 19 hours, the patient spontaneously awakened and produced roughly four hours of autobiographical speech.
By the first day, she showed increased alertness and recognition of family. By the second day, she was independently walking. By days two and three, she was dressing herself and showing spontaneous initiative. Around the same time, her diapers remained dry, including at night.
The improvement in continence was particularly notable to researchers because urinary control depends on more than a single simple reflex. It requires awareness of bodily signals, executive inhibition, and coordination among brain networks affected by dementia. The report states that the patient remained continent one month after the initial session, which was one reason a second session was performed.
During that second session, the patient reportedly remained more verbally expressive and described positive imagery involving surfing with her son on a peaceful island.
Researchers also observed improved facial expressivity, emotional reciprocity, spontaneous humor, and greater agility while walking. At one point during follow-up, the patient spontaneously said, “It is pleasant to come here.”
The study’s broader importance is in what it may suggest about the brain in advanced neurodegenerative disease. Alzheimer’s is usually understood as a progressive condition in which neurons and networks progressively deteriorate, stripping away memory, communication, mobility, and autonomy. By the advanced stage, treatment is largely supportive, and meaningful functional recovery is generally considered unlikely.
Psilocybin, however, is known to transiently alter large-scale brain dynamics via activation of the serotonin 5-HT2A receptor. Researchers point to prior human neuroimaging studies showing changes in default mode network integrity, network segregation, and functional connectivity after psilocybin administration. They also cited preclinical research suggesting psychedelics may promote structural and functional plasticity, including dendritic growth and synaptic remodeling.
That does not mean psilocybin repaired the patient’s Alzheimer’s disease. Instead, researchers suggest a more measured interpretation. The drug may have temporarily altered brain network activity, allowing remaining functional systems to reintegrate or become accessible again, at least for a limited period.
The report does not claim that plaques, tangles, or neurodegeneration were reversed. It also does not show that other patients would experience similar results. Because this was a single case, there was no control group, no placebo comparison, no formal biomarker confirmation, and no standardized cognitive testing to measure the degree of change.
Researchers acknowledge that mixed or alternative neurodegenerative contributions, including vascular components, cannot be fully excluded. Although they found no evidence of acute delirium, intoxication, or another acute neurological diagnosis during the observation period, the case remains observational. Causality cannot be established, and fluctuations in neurodegenerative disease cannot be completely ruled out.
The safety picture is also incomplete. While no severe persistent adverse effects, prolonged agitation, clinically significant cardiovascular instability, persistent psychotic symptoms, delayed neurological deterioration, or delayed medical complications were observed during follow-up, the acute phase included suspected hyperthermia and profuse sweating. In frail elderly patients, especially those with advanced dementia, such responses could carry serious risks.
For that reason, the findings should not be read as a green light for unsupervised psychedelic use in dementia patients. Psilocybin is still a powerful psychoactive compound, and older adults with complex neurological disease may be especially vulnerable to complications.
Ultimately, the value of the report doesn’t lie in providing a treatment recommendation but in documenting an unusual clinical observation that researchers say warrants controlled investigation.
The case also lands amid a flood of scientific interest in psychedelics as tools for studying brain plasticity, perception, memory, and large-scale network dysfunction.
More recently, researchers have begun asking whether similar neuromodulatory effects might have relevance for people with mild cognitive impairment or early Alzheimer’s disease.
Published clinical data involving advanced dementia remain extremely limited, which is why the new report is best understood not as evidence of a treatment, but as a provocative case study that may help guide future controlled research.
This recent case does not prove efficacy, but it questions assumptions about what may remain possible in a brain already deeply affected by Alzheimer’s disease.
If future studies find similar effects under supervised conditions, the implications could be significant, not only for dementia care but also regarding understanding how much latent function can persist beneath the outward appearance of severe decline.
“Residual functional capacity may persist in advanced Alzheimer’s disease and may become transiently accessible following psilocybin induced modulation of large-scale brain networks,” researchers conclude. “Systematic investigation is warranted.”
Tim McMillan is a retired law enforcement executive, investigative reporter and co-founder of The Debrief. His writing typically focuses on defense, national security, the Intelligence Community and topics related to psychology. You can follow Tim on Twitter:@LtTimMcMillan. Tim can be reached by email: tim@thedebrief.org or through encrypted email:LtTimMcMillan@protonmail.com
For many years, doctors have encouraged people with obesity to lose weight in order to improve their heart health. Even modest weight loss can reduce strain on the heart, improve blood sugar levels, and lower blood pressure. Now, a major new study suggests that the latest generation of weight-loss medications may deliver significant blood pressure […]
Millions of older adults worry about losing their strength and independence as they age. Many people fear not only serious illnesses such as heart disease or cancer but also the gradual loss of physical function that can make everyday tasks difficult. This condition, known as frailty, affects a growing number of older people around the […]
A new study involving almost one million patients is challenging one of the most influential ideas in modern heart care. Researchers from Tulane University report that not all women with atrial fibrillation have a higher risk of stroke than men, despite what many medical guidelines have assumed for years. The findings could eventually affect how […]
People with a rare condition experience "pauses" in their heart beat that cause them to faint. A new procedure could change their lives, research suggests.
A new study reveals that aging changes the body’s walking strategy, prioritizing balance and safety over efficiency. Walking may seem automatic, but every step requires a complex balance between stability, muscle coordination, and forward propulsion. As people age, that balance begins to shift. New research from Australia suggests the body gradually adopts a more cautious [...]
Researchers have identified a potential biological signature of sleep loss in saliva, bringing scientists closer to an objective test for detecting dangerous fatigue. A driver who has been awake for an entire day can be as impaired as someone who is legally intoxicated. Yet unlike alcohol, there is no roadside test that can objectively determine [...]
New ACC/AHA cholesterol guidelines promote earlier detection, personalized risk assessment, and more aggressive LDL cholesterol lowering to reduce long-term cardiovascular disease risk. For decades, cholesterol management has been a cornerstone of heart disease prevention. Yet despite widespread awareness, cardiovascular disease remains the leading cause of death worldwide, and millions of adults continue to have cholesterol [...]
Falling overboard from a ship is one of the most dangerous emergencies at sea. Every minute matters, and the chances of survival can quickly decrease as people become exhausted, suffer from cold water exposure, or drift far away from the vessel. Researchers at the Technical University of Denmark (DTU) are developing a new autonomous rescue […]
For decades, the possibility of discovering extraterrestrial intelligence has captured the imagination of scientists, sci-fi enthusiasts, filmmakers, and the public alike.
In line with such efforts, the IAA SETI Committee and the uNHIdden Foundation, two separate not-for-profit organizations, have recently released updated rules for evaluating and disclosing detections, and preparing for public preparedness in the event of potential disclosure of extraterrestrial intelligence.
With the release of director Steven Spielberg’s new alien film Disclosure Day, nearly coinciding with the recent release of the government records from the Department of War related to UAP, it seems a growing number of individuals, from the film industry to the science community, have extraterrestrials and “disclosure” on their minds.
The IAA SETI Committee Rules
In June 2026, the International Academy of Astronautics (IAA) approved a major update to the protocols governing the evaluation, verification, and communication of evidence related to extraterrestrial intelligence. The revised guidelines were designed to address a modern information environment shaped by social media, artificial intelligence, and the rapid pace of the 24-hour news cycle.
Professor Michael Garrett, Sir Bernard Lovell Chair of Astrophysics, led the international effort to revise the long-standing post-detection protocols used by researchers engaged in the search for extraterrestrial intelligence. The updated guidelines have since been formally ratified by the IAA.
“The information environment we operate in today is vastly more complex than it was in 2010,” said Garrett, Chair of the IAA SETI Committee, in a statement. “In an era of deepfakes, automated misinformation, and instant global connectivity, a single unverified claim could trigger confusion or panic. These new protocols ensure that scientists maintain the highest standards of evidence before making announcements to the world.”
The revised declaration reflects the broader scope of modern SETI and technosignature research. Since the previous guidelines were adopted in 2010, advances in technology have enabled scientists to investigate the entire electromagnetic spectrum, including excess infrared heat signatures that could indicate megastructures, optical laser emissions, and even multi-messenger signals.
The updated framework also addresses modern challenges, including protections for researchers who may face harassment, doxxing, or intense media scrutiny. It further emphasizes the importance of distinguishing verified scientific data from viral rumors, hoaxes, or terrestrial interference.
“The last significant update was more than 15 years ago, and the world has changed a lot since then,” Andrew Siemion, Ph.D., Astrophysics and Director of SETI Research, said an email to The Debrief. “With the tremendous renaissance we are seeing in the technosignature field, and the advent of incredibly powerful AI tools, the prospect for a discovery of extraterrestrial intelligence has sharpened considerably.”
“In recognition of these developments, the IAA SETI Committee undertook a multiyear expansive effort to work with scientists across the world and across disciplines to present the most up-to-date guidelines possible to the community,” Siemeon said.
New Contact Rules at SETI
At the heart of the new guidelines is a familiar scientific principle: extraordinary claims require extraordinary evidence.
Under the revised protocols, no public announcement should be made until a signal or artifact has been rigorously verified by independent organizations using different instruments and methodologies.
“We do not shout ‘alien’ the moment we see a strange blip,” said Garret in a statement. “The scientific method demands we check, check again, and then ask others to check. Only when we have reached a consensus that a signal is credible do we bring it to the world.”
While the protocols explain how to share discovery news, they make one rule clear: no reply should be sent.
“The threshold for ‘extraordinary evidence’ is subjective,” Siemion says. “Because of the vast diversity of modalities in which a technosignature might manifest, it is impossible to state explicitly the criteria that would meet this threshold under all circumstances.”
“In the case of a coherent electromagnetic signal, like a narrowband carrier or a series of laser pulses, an example of ‘extraordinary’ would be if we repeatedly detected the signal at the same location with multiple independent observatories,” Siemion adds.
He also noted that, for a transient signal, compelling evidence might include multiple lines of data indicating that it traveled through interstellar space. Determining whether a phenomenon truly originated from extraterrestrial technology would likely be a lengthy process, with evidence presented, challenged, and reassessed over time.
The declaration reinforces that any response to extraterrestrial intelligence would be a decision for all humanity and should only occur following international consultation, particularly through the United Nations.
With the updated declaration now ratified by the IAA Board, it will be shared with stakeholders, including the United Nations. A formal presentation of the protocols is scheduled for the International Astronautical Congress (IAC) in Türkiye later this year.
“The release of these updated rules and protocols marks an important step in acknowledging both the radically different media landscape that science functions within today, and the vastly expanded efforts in terms of technology and resources being deployed in the search for intelligent life beyond Earth,” said Bill Diamond, President and CEO of the SETI Institute and IAA SETI Committee member. “We applaud Prof Garrett’s leadership in developing these new protocols and the IAA for their ratification.”
First Contact and Humanity’s Mental Health
Another nonprofit organization has taken a different approach, focusing on the potential psychological and public-health implications of disclosure. The uNHIdden Foundation, whose mission is to support mental health related to Unidentified Anomalous Phenomena (UAP), recently released a preparedness framework addressing the societal impact of a paradigm-shifting discovery.
If governments prepare for natural disasters, pandemics, and other low-probability, high-impact events, should humanity also consider preparing for the possibility of contact with another intelligent civilization?
On June 8, uNHIdden Foundation Founder and Chairman John Priestland, alongside clinical spokesperson Dr. Martin Abbas, launched what they describe as the first public-health preparedness framework focused on disclosure-related scenarios.
Developed by healthcare practitioners, physicians, clinical psychologists, and public-health specialists, “Preparing for Disclosure: A Public Health Framework for Paradigm-Shifting Revelations” examines how society might reduce harm, build resilience, and support individuals processing a profound shift in humanity’s understanding of its place in the universe.
“This report is not a prediction. It is a preparedness exercise,” Priestland says. “Governments prepare for all kinds of low-probability, high-impact events.”
“Our view is that if a paradigm-shifting disclosure were ever to occur, we should at least have thought about the human consequences in advance,” Priestland added.
The report suggests that certain groups could be more vulnerable to disclosure-related distress, including individuals with pre-existing mental health conditions, those facing socioeconomic hardship, UAP experiencers, highly religious individuals, and some STEM professionals. The authors emphasize that the report neither predicts disclosure nor attempts to judge future discoveries; rather, it argues that preparedness is a prudent response to the possibility of transformative new information.
David Whitehouse, former BBC Science Correspondent, wrote the report’s foreword, arguing that planning is essential should such a discovery ever occur.
The new framework proposes several practical actions to be taken, which include:
Reducing stigma surrounding anomalous experiences and disclosure-related concerns
Building public resilience and psychological flexibility
Developing trusted sources of information and support
Creating community conversation groups and peer-support networks
Strengthening mental health preparedness and triage capability
Encouraging collaboration between healthcare professionals, researchers, government, and civil society
The report argues that stronger community resilience, clearer communication during periods of uncertainty, and improved mental-health support would be critical not only during a disclosure event but during any large-scale societal disruption.
Ultimately, the question remains whether humanity is truly prepared—or whether a globally coordinated framework is still lacking. Voices ranging from the UAP community to figures within the U.S. government have argued that the public is ready. However, only time will tell what the result may be if confirmation of extraterrestrial intelligence were to arrive—and how humanity will collectively respond to the discovery.
Chrissy Newton is a PR professional and the founder of VOCAB Communications. She currently appears on The Discovery Channel and Max and hosts the Rebelliously Curious podcast, which can be found on YouTube and on all audio podcast streaming platforms. Follow her on X: @ChrissyNewton, Instagram: @BeingChrissyNewton, and chrissynewton.com. To contact Chrissy with a story, please email chrissy @ thedebrief.org.
Repeated doses of a tuberculosis vaccine lowered insulin needs in patients with two forms of diabetes, new trial data show. But more research is needed to prove the benefit.
The breast cancer 'breakthrough' is a story of overtreatment, not a triumph of testing, says Dr Clare Craig. The truth is, the genetic test failed, but it's being rolled out anyway.
Scientists discovered a surprising gut-heart connection that may help prevent sleep apnea from causing serious cardiovascular damage. Sleep apnea affects millions of people worldwide and is known to raise the risk of serious cardiovascular problems. Now, researchers have identified a potential new treatment target that could help reduce some of the condition’s harmful effects. Findings [...]
Login
Cases are becoming increasingly familiar.
